{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_004562.3:c.124A>G",
          "cDNA Change": {
            "transcript": "NM_004562.3",
            "ref": "A",
            "alt": "G",
            "position": "124"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "V",
            "position": "42"
          },
          "Description in input context": "c.124A>G (p.I42V)"
        },
        {
          "HGVS": "NM_004562.3:c.823C>T",
          "cDNA Change": {
            "transcript": "NM_004562.3",
            "ref": "C",
            "alt": "T",
            "position": "823"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "W",
            "position": "275"
          },
          "Description in input context": "c.823C>T (p.R275W)"
        },
        {
          "HGVS": "NM_004562.3:c.1030A>G",
          "cDNA Change": {
            "transcript": "NM_004562.3",
            "ref": "A",
            "alt": "G",
            "position": "1030"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "G",
            "position": "344"
          },
          "Description in input context": "c.1030A>G (p.E344G)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Glioblastoma Multiforme, Colon Cancer, Lung Cancer",
    "MONDO": "MONDO:0018177 (Glioblastoma), MONDO:0005575 (Colon Cancer), MONDO:0008903 (Lung Cancer)"
  },
  "Experiment Method": [
    {
      "Assay Method": "Colony Formation Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "T98G, DBTRG, RKO, H441, H358",
        "Description": "Human cancer cell lines lacking or expressing PARK2 were used for transfection and colony formation assays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004562.3:c.124A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Expression of PARK2 with tumor-derived mutation c.124A>G resulted in decreased colony-forming activity compared to wild-type PARK2."
        },
        {
          "Variant": "NM_004562.3:c.823C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Expression of PARK2 with tumor-derived mutation c.823C>T resulted in decreased colony-forming activity compared to wild-type PARK2."
        },
        {
          "Variant": "NM_004562.3:c.1030A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Expression of PARK2 with tumor-derived mutation c.1030A>G resulted in decreased colony-forming activity compared to wild-type PARK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were performed in triplicate."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 was used as a positive control for colony suppression."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Vector-only control (pcDNA3.1) was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-tailed Student's t-test and ANOVA were used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Colony formation activity comparable to wild-type PARK2 transfected cells.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly reduced colony formation activity compared to wild-type PARK2 transfected cells (P < 0.001).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Ubiquitination Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "T98G",
        "Description": "T98G cells were transfected with hemagglutinin-ubiquitin (HA-Ub), vector only, wild-type PARK2, or mutant PARK2 cDNAs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004562.3:c.124A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Mutation c.124A>G substantially decreased PARK2's E3 ligase function and ability to ubiquitinate cyclin E."
        },
        {
          "Variant": "NM_004562.3:c.823C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Mutation c.823C>T substantially decreased PARK2's E3 ligase function and ability to ubiquitinate cyclin E."
        },
        {
          "Variant": "NM_004562.3:c.1030A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Mutation c.1030A>G substantially decreased PARK2's E3 ligase function and ability to ubiquitinate cyclin E."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 was used as a positive control for ubiquitination activity."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Vector-only control (pcDNA3.1) was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-tailed Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitination activity comparable to wild-type PARK2 transfected cells.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly reduced ubiquitination activity compared to wild-type PARK2 transfected cells (P < 0.05).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Flow Cytometry Analysis",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Various cancer cell lines",
        "Description": "Cells were analyzed following PARK2 knockdown for cell cycle distribution."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004562.3:c.124A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "PARK2 knockdown (including mutations like c.124A>G) increased the proportion of cells in S and G2-M phases."
        },
        {
          "Variant": "NM_004562.3:c.823C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "PARK2 knockdown (including mutations like c.823C>T) increased the proportion of cells in S and G2-M phases."
        },
        {
          "Variant": "NM_004562.3:c.1030A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "PARK2 knockdown (including mutations like c.1030A>G) increased the proportion of cells in S and G2-M phases."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were performed in triplicate."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Scrambled siRNA controls were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell cycle distribution comparable to control cells with scrambled siRNA.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant increase in S and G2-M phase cells compared to control cells.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}